Pharmaco-metabolomics

Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.

 

    Related Conference of Pharmaco-metabolomics

    April 30-30, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    May 17-18, 2021

    11th World Glycobiology Congress

    Vienna, Austria
    July 26-27, 2021

    5th International Conference on Bioscience and Biotechnology

    London, Aland Islands
    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    July 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    August 17-18, 2021

    23rd Global Biotechnology Congress

    Rome, Italy
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 03-04, 2021

    International Conference on Biotechnology

    Singapore, Singapore

    Pharmaco-metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in